Prognostic value of the preoperative neutrophil to lymphocyte ratio in resectable gastric cancer

Medicine (United States)

Volumn 94, Issue 39, 2015, Pages e1589-

  Hsu, Jun Te ^a   Liao, Chun Kai ^a   Le, Puo Hsien ^a   Chen, Tsung Hsing ^a   Lin, Chun Jung ^a   Chen, Jen Shi ^a   Chiang, Kun Chun ^a   Yeh, Ta Sen ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PERINEURAL INVASION; PLATELET LYMPHOCYTE RATIO; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; AGED; BLOOD; GASTRECTOMY; KAPLAN MEIER METHOD; LYMPHOCYTE; METABOLISM; METASTASIS; MORTALITY; NEUTROPHIL; PATHOLOGY; PREOPERATIVE PERIOD; STOMACH NEOPLASMS;

AGED; FEMALE; GASTRECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEUTROPHILS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84943167144     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001589     Document Type: Article

References (30)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-E386.
2. Wang F, Chang YC, Chen TH, et al. Prognostic significance of splenectomy for gastric cancer patients undergoing total gastrectomy: a retrospective cohort study. Int J Surg. 2014;12:557-565.
3. Wagner AD, Grothe W, Haerting J, et al. Chemotherapy in advanced gastric cancer: a systematic review and meta-Analysis based on aggregate data. J Clin Oncol. 2006;24:2903-2909.
4. Edge SB, Byrd DR, Compton CC, et al. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2009.
5. Li MX, Liu XM, Zhang XF, et al. Prognostic role of neutrophil-tolymphocyte ratio in colorectal cancer: a systematic review and metaanalysis. Int J Cancer. 2014;134:2403-2413.
6. Sugiura T, Uesaka K, Kanemoto H, et al. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after gastroenterostomy in patients with advanced pancreatic adenocarcinoma. Ann Surg Oncol. 2013;20:4330-4337.
7. Gao F, Li X, Geng M, et al. Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma. Medicine. 2015;94:e639.
8. Pistelli M, De Lisa M, Ballatore Z, et al. Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients. BMC Cancer. 2015;15:195.
9. Chen J, Hong D, Zhai Y, et al. Meta-Analysis of associations between neutrophil-to-lymphocyte ratio and prognosis of gastric cancer. World J Surg Oncol. 2015;13:122.
10. Zhang X, Zhang W, Feng LJ. Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-Analysis. PLoS ONE. 2014;9:e111906.
11. Graziosi L, Marino E, De Angelis V, et al. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer. Am J Surg. 2015;209:333-337.
12. Ishizuka M, Oyama Y, Abe A, et al. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancer. J Surg Oncol. 2014;110:935-941.
13. Sano T, Aiko T. New Japanese Classifications and Treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer. 2011;14:97-100.
14. Cheng TC, Tsai CY, Hsu JT, et al. Aggressive surgical approach for patients with T4 gastric carcinoma: promise or myth? Ann Surg Oncol. 2011;18:1606-1614.
15. Shimada H, Takiguchi N, Kainuma O, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer. 2010;13:170-176.
16. Lee S, Oh SY, Kim SH, et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350.
17. Wang DS, Ren C, Qiu MZ, et al. Comparison of the prognostic value of various preoperative inflammation-based factors in patients with stage III gastric cancer. Tumour Biol. 2012;33:749-756.
18. Jung MR, Park YK, Jeong O, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol. 2011;104:504-510.
19. Cho IR, Park JC, Park CH, et al. Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer. Gastric Cancer. 2014;17:703-710.
20. Jeong JH, Lim SM, Yun JY, et al. Comparison of two inflammationbased prognostic scores in patients with unresectable advanced gastric cancer. Oncology. 2012;83:292-299.
21. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860-867.
22. Fang H, Declerck YA. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials. Cancer Res. 2013;73:4965-4977.
23. Wu T, Li Y, Lu J, et al. Increased MMP-21 expression is associated with poor overall survival of patients with gastric cancer. Med Oncol. 2013;30:323.
24. Dumitru CA, Lang S, Brandau S. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Semin Cancer Oncol. 2013;23:141-148.
25. Shau H, Kim H. Suppression of lymphokine-Activated killer induction by neutrophils. J Immunol. 1988;141:4395-4402.
26. van Egmond M, Bakema JE. Neutrophils as effector cells for antibodybased immunotherapy of cancer. Semin Cancer Biol. 2013;23:190-199.
27. Toge T, Yamaguchi Y. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. Oncol Rep. 2000;7:1157-1161.
28. Namikawa T, Fukudome I, Ogawa M, et al. Clinical efficacy of protein-bound polysaccharide K in patients with gastric cancer undergoing chemotherapy with an oral fluoropyrimidine (S-1). Eur J Surg Oncol. 2015;41:795-800.
29. Xiao LJ, Zhao S, Zhao EH, et al. Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas. Oncol Lett. 2013;6:1277-1284.
30. Wang QX, Zhu YQ, Zhang H, et al. Altered miRNA expression in gastric cancer: a systematic review and meta-Analysis. Cell Physiol Biochem. 2015;35:933-944.